Covid 19 reagents
Ended Awarded Last action
- Contract number
- N6264520F0274
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $127,100
Award facts
- Opportunity
-
- Covid-19 Solicitation · N6264520Q0017 · Posted May 12, 2020
- Contract value 100% obligated
- $127,100.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$750 | |
| Supplemental Agreement for work within scope | $750 | |
| Original award | $127,100 |
About this award
This is a federal contract award from the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, to provide COVID-19 testing reagents and the APTIMA SARS-CoV-2 ASSAY. The $127,100.00 fixed-price contract was awarded on August 7, 2020 with a completion date of September 6, 2020. It was not set aside for a specific business type.
Gen-Probe Incorporated is a key supplier of molecular diagnostic products and services to various federal agencies, including the Department of Defense and Department of Veterans Affairs. The company has held numerous contracts to provide infectious disease testing capabilities, and has supplied a range of COVID-19 testing supplies and equipment during the pandemic through contracts with the Defense Health Agency, Army Medical Command, and Navy Bureau of Medicine and Surgery. This award is likely part of the company's broader IDCs and BPAs with these agencies to rapidly procure critical diagnostic products to support healthcare and pandemic response efforts for military personnel, veterans, and their families.
Quick answers
Who was awarded contract N6264520F0274?
N6264520F0274 was awarded to Gen-Probe Incorporated by Bureau of Medicine and Surgery (Department of the Navy) on August 7, 2020.
How much is contract N6264520F0274 worth?
The government has obligated $127,100 on N6264520F0274.
Which agency awarded contract N6264520F0274?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6264520F0274, with funding from Defense Health Agency (Department of Defense).
Is contract N6264520F0274 an order under another contract?
Yes. N6264520F0274 is a delivery order under N6264520D5007, an indefinite delivery contract.
Was contract N6264520F0274 competed?
The extent of competition for N6264520F0274 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award